Monovalent Rotavirus Vaccine Effectiveness Against Rotavirus Hospitalizations Among Children in Zimbabwe
This article, published in Clinical Infectious Diseases, reports the results of a study that evaluated monovalent rotavirus vaccine effectiveness in Zimbabwe under routine surveillance conditions following the vaccine's introduction in 2014. The study results indicate a vaccine effectiveness against severe rotavirus disease among infants to be 68 percent. The authors conclude that the monovalent rotavirus vaccine is effective in preventing hospitalizations due to severe rotavirus diarrhea among infants in Zimbabwe, providing additional evidence that live, oral rotavirus vaccines are effective in high-child-mortality settings.
Author: Mujuru HA, Burnett E, Nathoo KJ, et al.
» Visit web page (English)
(Located at academic.oup.com)
Citation: Mujuru HA, Burnett E, Nathoo KJ, et al. Monovalent Rotavirus Vaccine Effectiveness Against Rotavirus Hospitalizations Among Children in Zimbabwe. Clinical Infectious Diseases. 2018;Early Online Publication.
Resource types: Peer-reviewed journal